Vimarsana
Biggest News Aggregation in the World

Page 21 - Merck Sharp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Merck Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Merck Sharp Today - Breaking & Trending Today

PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors - Vimarsana News

PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors

/PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on next-generation antibody therapeutics, announced today the...

Ganirelix Market | Ambinter, BLD Pharm, Chemenu - Vimarsana News

Ganirelix Market | Ambinter, BLD Pharm, Chemenu

Ganirelix Market | Ambinter, BLD Pharm, Chemenu

1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort study - Vimarsana News

1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort study

In this population based cohort study of >37,000 people in Hong Kong, Hongjiang Wu and colleagues examine 1-year weight change after diabetes diagnosis with long-term incidence and sustainability of diabetes remission.

Source: plos.org
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer - PDS Biotechnology (NASDAQ:PDSB) - Vimarsana News

PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer - PDS Biotechnology (NASDAQ:PDSB)

PRINCETON, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or "the Company"), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer

Spending to lobby Kentucky legislature hit all-time high in 2023, spurred by gambling bills - NKyTribune - Vimarsana News

Spending to lobby Kentucky legislature hit all-time high in 2023, spurred by gambling bills - NKyTribune

By Tom LoftusKentucky LanternGambling interests drove lobbying spending in Frankfort to a record level in 2023.More than 800 corporations, associations and other groups reported spending $24